Tazobactam sodium salt, beta-lactamase inhibitor

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein known as Beta-lactamase often referred to as Beta-lactamase TEM precursor or simply Beta-lactamase plays an important mechanical role in antibiotic resistance by breaking open the beta-lactam ring found in many penicillins and cephalosporins disabling their antibacterial properties. This enzyme weighs approximately 29 kDa. It is most commonly expressed in Gram-negative bacteria including Escherichia coli. Beta-lactamase is one of the primary defenses bacteria use against the beta-lactam class of antibiotics.

Biological function summary

Beta-lactamase enzymes allow bacteria to survive in environments with the presence of beta-lactam antibiotics. These enzymes do not form part of a larger complex but function independently. The production of beta-lactamase enables bacteria to deactivate important components of antibiotic function providing a considerable survival advantage. In certain strains Beta-lactamase exists alongside beta-lactamase inhibitors like tazobactam which help combat this resistance by neutralizing the enzyme's effects.

Pathways

Beta-lactamase activity is integral to the resistance pathways against antibiotics in bacterial cells. Major pathways include the synthesis and regulation of beta-lactamases in resistant bacteria environments. Beta-lactamase interacts with proteins involved in bacterial cell wall synthesis where it impacts the antibiotic's intended action. Related proteins in these pathways may include penicillin-binding proteins which are often the target of beta-lactam antibiotics.

Beta-lactamase significantly relates to bacterial infections particularly those that result in antibiotic resistance. Two major concerns are nosocomial infections and urinary tract infections caused by resistant strains of bacteria. The expression of Beta-lactamase in these conditions relates to proteins such as extended-spectrum beta-lactamases (ESBLs) which also confer resistance to the bacteria. Understanding and targeting Beta-lactamase via inhibitors remains a significant focus of research to tackle these resistant bacterial infections effectively.